Recombinant Human EGF
To Order Contact us: lieven@wlsolutions.be
Human Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-Hu-96Tests | 96 Tests | EUR 480 |
Human Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-Hu-48Tests | 48 Tests | EUR 368.4 |
Human Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-Hu-96Tests | 96 Tests | EUR 501.6 |
Mouse Epidermal Growth Factor (EGF) ELISA Kit, 96 tests, quantitative |
||
210-150-EGF | 1 Kit | EUR 927.6 |
Mouse Epidermal Growth Factor (EGF) ELISA Kit |
||
DLR-EGF-Mu-48T | 48T | EUR 378 |
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor (EGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Epidermal Growth Factor (EGF) ELISA Kit |
||
DLR-EGF-Mu-96T | 96T | EUR 475.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor (EGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Epidermal Growth Factor (EGF) ELISA Kit |
||
DLR-EGF-p-48T | 48T | EUR 591.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Epidermal Growth Factor (EGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Epidermal Growth Factor (EGF) ELISA Kit |
||
DLR-EGF-p-96T | 96T | EUR 769.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Epidermal Growth Factor (EGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Epidermal Growth Factor (EGF) ELISA Kit |
||
DLR-EGF-Ra-48T | 48T | EUR 446.4 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor (EGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Epidermal Growth Factor (EGF) ELISA Kit |
||
DLR-EGF-Ra-96T | 96T | EUR 570 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor (EGF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-Mu-48Tests | 48 Tests | EUR 351.6 |
Mouse Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-Mu-96Tests | 96 Tests | EUR 477.6 |
Porcine Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-p-48Tests | 48 Tests | EUR 592.8 |
Porcine Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-p-96Tests | 96 Tests | EUR 820.8 |
Rat Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-Ra-48Tests | 48 Tests | EUR 429.6 |
Rat Epidermal Growth Factor (EGF) ELISA Kit |
||
RD-EGF-Ra-96Tests | 96 Tests | EUR 588 |
Mouse Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-Mu-48Tests | 48 Tests | EUR 366 |
Mouse Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-Mu-96Tests | 96 Tests | EUR 498 |
Porcine Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-p-48Tests | 48 Tests | EUR 619.2 |
Porcine Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-p-96Tests | 96 Tests | EUR 859.2 |
Rat Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-Ra-48Tests | 48 Tests | EUR 448.8 |
Rat Epidermal Growth Factor (EGF) ELISA Kit |
||
RDR-EGF-Ra-96Tests | 96 Tests | EUR 614.4 |
Recombinant Human EGF |
||
SJA08-01 | 100µg/vial | EUR 168 |
EGF Receptor, human recombinant |
||
7135-10 | EUR 280.8 |
EGF Receptor, human recombinant |
||
7135-50 | EUR 1032 |
HB-EGF, human recombinant |
||
4266-10 | EUR 164.4 |
HB-EGF, human recombinant |
||
4266-1000 | EUR 2408.4 |
HB-EGF, human recombinant |
||
4266-50 | EUR 301.2 |
Recombinant Human EGF Protein |
||
RP01030 | 20 μg | EUR 151.2 |
Human CellExp? EGF, human recombinant |
||
7228-10 | EUR 352.8 |
EGF Recombinant Protein |
||
40-450-01mg | 0.1 mg | EUR 311.1 |
Description: Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-alpha and VGF (vaccinia virus growth factor). Recombinant murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide-bonds. |
EGF Recombinant Protein |
||
40-450-05mg | 0.5 mg | EUR 437.1 |
Description: Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-alpha and VGF (vaccinia virus growth factor). Recombinant murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide-bonds. |
EGF Recombinant Protein |
||
40-477-002mg | 0.02 mg | EUR 311.1 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues including 3 intramolecular disulfide-bonds. |
EGF Recombinant Protein |
||
40-477-01mg | 0.1 mg | EUR 437.1 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues including 3 intramolecular disulfide-bonds. |
EGF Recombinant Protein |
||
91-020 | 0.05 mg | EUR 374.1 |
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF is a small 53 amino acid residue long protein that contains three disulfide bridges |
EGF Recombinant Protein |
||
92-245 | 0.05 mg | EUR 374.1 |
Description: EGF is a single-pass type I membrane protein,containing 8 LDL-receptor class B repeats and 9 EGF-like domains. EGF results in cellular proliferation, differentiation, and survival.EGF is a low-molecular-weight polypeptide first purified from the mouse submandibular gland, but since then found in many human tissues including submandibular gland, parotid gland. Salivary EGF, which seems also regulated by dietary inorganic iodine, also plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. |
EGF Recombinant Protein |
||
40-586-01mg | 0.1 mg | EUR 311.1 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-a and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. |
EGF Recombinant Protein |
||
40-586-05mg | 0.5 mg | EUR 437.1 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-a and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. |
EGF, murine recombinant |
||
4023-100 | EUR 164.4 |
EGF, murine recombinant |
||
4023-1000 | EUR 385.2 |
EGF, murine recombinant |
||
4023-500 | EUR 307.2 |
EGF, murine recombinant |
||
4023-5000 | EUR 1299.6 |
EGF, rat recombinant |
||
4024-100 | EUR 364.8 |
EGF, rat recombinant |
||
4024-1000 | EUR 2173.2 |
EGF, rat recombinant |
||
4024-20 | EUR 192 |
EGF Recombinant Protein |
||
11-373 | 0.1 mg | EUR 651.3 |
Description: Human epidermal growth factor (EGF) is also known as HOMG4 and URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk. |
EGF Recombinant Protein |
||
11-495 | 0.1 mg | EUR 651.3 |
Description: Human epidermal growth factor (EGF) is also known as HOMG4 and URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk. |
EGF Recombinant Protein |
||
90-455 | 100 ug | EUR 437.1 |
Description: Epidermal growth factor (EGF) is a growth factor and the founding member of the EGF family. All EGF family members are synthesized as type I transmembrane precursor proteins that may contain several EGF domains in the extracellular region. The mature proteins are released from the cell surface by regulated proteolysis. EGF is present in various body fluids, including blood, milk, urine, saliva, seminal fluid, pancreatic juice, cerebrospinal fluid, and amniotic fluid. Four ErbB (HER) family receptor tyrosine kinases including EGFR/ErbB1, ErbB2, ErbB3 and ErbB4, mediate responses to EGF family members. These receptors undergo a complex pattern of ligand induced homo or heterodimerization to transduce EGF family signals. EGF binds to the receptor EGFR stimulating the intrinsic protein-tyrosine kinase activity of the receptor. The tyrosine kinase activity initiates a signal transduction cascade that results in a variety of biochemical changes within the cell, including a rise in intracellular calcium levels, increased glycolysis and protein synthesis, and increases in the expression of certain genes including the gene for EGFR, which lead to DNA synthesis, cell growth, proliferation and differentiation. Other biological activities ascribed to EGF include epithelial development, angiogenesis, inhibition of gastric acid secretion, fibroblast proliferation, and colony formation of epidermal cells in culture. Defects in EGF are the cause of hypomagnesemia type 4 (HOMG4), also known as renal hypomagnesemia normocalciuric. HOMG4 is a disorder characterized by massive renal hypomagnesemia and normal levels of serum calcium and calcium excretion. Clinical features include seizures, mild-to mederate psychomotor retardation, and brisk tendon reflexes. |
EGF, Human |
||
HY-P7109 | 50ug | EUR 129.6 |
Recombinant Human HB-EGF Protein |
||
PROTQ99075-2 | 50ug | EUR 380.4 |
Description: HB-EGF is an EGF related growth factor that signals through the EGF receptor, and stimulates the proliferation of smooth muscle cells (SMC), fibroblasts, epithelial cells, and keratinocytes. HB-EGF is expressed in numerous cell types and tissues, including vascular endothelial cells and SMC, macrophages, skeletal muscle, keratinocytes, and certain tumor cells. The ability of HB-EGF to specifically bind heparin and heparin sulfate proteoglycans is distinct from other EGF-like molecules, and may be related to the enhanced mitogenic activity, relative to EGF, that HB-EGF exerts on smooth muscle cells. The human HB-EGF gene encodes a 208 amino acid transmembrane protein, which can be proteolytically cleaved to produce soluble HB-EGF. Recombinant human HB-EGF is a 9.7 kDa protein containing 86 amino acid residues, corresponding to the extra-cellular EGF-like and heparin binding domains of the full length HB-EGF protein. |
Recombinant Human EGF-L7 Protein |
||
PROTQ9UHF1 | 10ug | EUR 380.4 |
Description: EGF-L7 (Epidermal Growth Factor Like Protein 7, Multiple EGF Like Domains Protein 7, VE Statin) is a multi-domain protein containing two EGF like domains and one EMI domain. It is expressed almost exclusively in endothelial cells and functions to promote normal development of the vascular system, particularly tubulogenesis. EGF-L7 is capable of antagonistic binding to Notch receptors resulting in the inhibition of Notch signaling in HUVEC and neural stem cells. In research models inducing hypoxia and subsequent reoxygenation, (H/R), EGF-L7 can inhibit ICAM-1 expression and enhance the inhibition of NF-kappaB activation. Additionally, EGF-L7 can chemoattract endothelial cells and bind to the extracellular matrix. The overexpression of EGF-L7 is observed in various cancers, and is generally correlated with increased metastasis and a poor prognosis. Recombinant human EGF-L7 is a 28 kDa protein containing 251 amino acid residues. |
Recombinant Human Epidermal Growth Factor/EGF |
||
C029-10ug | 10ug | EUR 84 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
Recombinant Human Epidermal Growth Factor/EGF |
||
C029-1mg | 1mg | EUR 230.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
Recombinant Human Epidermal Growth Factor/EGF |
||
C029-500ug | 500ug | EUR 178.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
Recombinant Human Epidermal Growth Factor/EGF |
||
C029-50ug | 50ug | EUR 120 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, pH 7.0. |
Epidermal Growth Factor (EGF), human recombinant |
||
4022-100 | EUR 176.4 |
Epidermal Growth Factor (EGF), human recombinant |
||
4022-1000 | EUR 424.8 |
Epidermal Growth Factor (EGF), human recombinant |
||
4022-500 | EUR 320.4 |
Epidermal Growth Factor (EGF), human recombinant |
||
4022-5000 | EUR 1358.4 |
Epidermal Growth Factor (EGF), human recombinant |
||
P1008-.1 | 100 µg | EUR 193.2 |
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR. |
Epidermal Growth Factor (EGF), human recombinant |
||
P1008-.5 | 500 µg | EUR 375.6 |
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR. |
Epidermal Growth Factor (EGF), human recombinant |
||
P1008-1 | 1 mg | EUR 477.6 |
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR. |
Epidermal Growth Factor (EGF), human recombinant |
||
P1008-5 | 5 mg | EUR 1646.4 |
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR. |
Genorise® recombinant human EGF protein |
||
GR119159 | 10 µg | EUR 231.6 |
Recombinant Human EGF Receptor (EGFR) Protein |
||
PROTP00533-3 | 10ug | EUR 380.4 |
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGFα, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions. |
EGF receptor Recombinant Protein |
||
40-516-0002mg | 0.002 mg | EUR 311.1 |
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGF, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions. |
EGF receptor Recombinant Protein |
||
40-516-001mg | 0.01 mg | EUR 437.1 |
Description: EGF Receptor (EGFR, ErbB1) is a transmembrane protein that exerts tyrosine kinase activity upon ligand induced activation. EGFR can be activated by binding EGF or at least six other structurally related protein ligands, including TGF, HB-EGF, Betacellulin (BTC), Amphiregulin, Epiregulin, and Epigen. Upon activation, EGFR initiates a signaling cascade which includes dimerization and internalization, tyrosine phosphorylation, DNA synthesis of target genes, and, ultimately, cell proliferation. EGFR signaling plays a role in the growth and differentiation of normal cells, but elevated EGFR activity is correlated with the development and pathogenesis of certain cancers. Recombinant soluble human EGFR is a 621 amino acid glycoprotein comprising the extracellular domain of EGFR, and migrates at an apparent MW of 97.5 kDa by SDS-PAGE analysis under reducing conditions. |
HB-EGF, mouse recombinant |
||
4267-10 | EUR 189.6 |
HB-EGF, mouse recombinant |
||
4267-1000 | EUR 3021.6 |
HB-EGF, mouse recombinant |
||
4267-50 | EUR 373.2 |
HB-EGF Recombinant Protein |
||
40-630 | 10 ug | EUR 311.1 |
Description: HB-EGF is an EGF-related growth factor that signals through the EGF receptor, and stimulates the proliferation of smooth muscle cells (SMC), fibroblasts, epithelial cells, and keratinocytes. HB-EGF is expressed in numerous cell types and tissues, including vascular endothelial cells, and vascular SMC, macrophages, skeletal muscle, keratinocytes, and certain tumor cells. The ability of HB-EGF to specifically bind heparin and heparin sulfate proteoglycans is distinct from other EGF-like molecules, and may be related to the enhanced mitogenic activity, relative to EGF, that HB-EGF exerts on smooth muscle cells. The human HB-EGF gene encodes a 208 amino acid transmembrane protein, which can be proteolytically cleaved to produce soluble HB-EGF. Recombinant Human HB-EGF is a 9.7 kDa protein containing 86 amino acid residues, corresponding to the extracellular EGF-like and heparin-binding domains of the full length HB-EGF protein. |
EGF-L7 Recombinant Protein |
||
40-632 | 2 ug | EUR 311.1 |
Description: EGF-L7 (Epidermal growth factor-like protein 7, Multiple EGF-like domains protein 7, VE-statin) is a multi-domain protein containing two EGF-like domains and one EMI domain. It is expressed almost exclusively in endothelial cells and functions to promote normal development of the vascular system, particularly tubulogenesis. EGF-L7 is capable of antagonistic binding to Notch receptors, resulting in the inhibition of Notch signaling in HUVEC and neural stem cells. In research models inducing hypoxia and subsequent reoxygenation (H/R), EGF-L7 can inhibit ICAM-1 expression and enhance the inhibition of NF-κB activation. Additionally, EGF-L7 can chemoattract endothelial cells and bind to the extracellular matrix. The overexpression of EGF-L7 is observed in various cancers, and is generally correlated with increased metastasis and a poor prognosis. Recombinant Human EGF-L7 is a 27.4 kDa protein containing 251 amino acid residues. |
EGF-L7 Recombinant Protein |
||
40-633 | 10 ug | EUR 311.1 |
Description: Originally identified as a differentiation antigen of mesotheliomas, ovarian cystadenocarcinomas, and pancreatic adenocarcinomas, Mesothelin is a glycosylphosphatidylinositol (GPI)-anchored, cell-surface glycoprotein predominantly secreted by cells of the mesothelium. Although Mesothelin is expressed at restricted levels by normal mesothelial cells of the pleural,pericardial, and peritoneal membranes, aberrant expression has been documented in the aforementioned cancers, as well as in endometriod uterine adenocarcinomas and squamous cell carcinomas of the esophagus, stomach, lung, and cervix. Proteolytic cleavage of Mesothelin yields a soluble, polypeptide fragment designated megakaryocyte potentiating factor (MPF) based on its ability to stimulate megakaryocyte colony-forming activity of murine interleukin-3 in murine bone marrow cell cultures. Originally isolated from the HPC-Y5 pancreatic cell line, MPF has been suggested to play a role in the proliferation and differentiation of megakaryoctyes, and the regulation of resultant platelet production. While the biological functions of both Mesothelin and MPF remain speculative, high-levels of expression in cancerous tissues compared to limited distribution in normal tissues strongly suggests their involvement in tumorigenesis. Both have been demonstrated to promote tumor cell proliferation, migration,anchorage-independent growth, and tumor progression; demonstrating their involvement in heterotypic cell adhesion and the metastatic spread of cancer. CHO cell-derived Recombinant Human MPF is the 250 amino acid-length fragment of the Mesothelin sequence, and has a calculated molecular weight of approximately 26.7 kDa. As a result of glycosylation, Recombinant Human MPF migrates with an apparent molecular mass of approximately 32-33 kDa by SDS-PAGE gel, under reducing and non-reducing conditions. |
EGF R Recombinant Protein |
||
11-547 | 0.1 mg | EUR 519 |
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. |
EGF R Recombinant Protein |
||
11-548 | 0.1 mg | EUR 714.3 |
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. |
EGF R Recombinant Protein |
||
11-470 | 0.1 mg | EUR 884.4 |
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. |
EGF recombinant monoclonal antibody |
||
A5094 | 100ul X 3 | EUR 714 |
Description: A recombinant monoclonal antibody from rabbit against human EGF for WB,ELISA |
EGF R Recombinant Protein |
||
97-062 | 0.05 mg | EUR 588.3 |
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. |
EGF R Recombinant Protein |
||
97-063 | 0.1 mg | EUR 588.3 |
Description: The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. |
Recombinant Rat EGF Protein |
||
PROTP07522-2 | 100ug | EUR 380.4 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues including 3 intramolecular disulfide-bonds. |
Recombinant Murine EGF Protein |
||
PROTP01132-4 | 500ug | EUR 380.4 |
Description: Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide-bonds. |
Recombinant Mouse EGF Protein |
||
RP00628 | 10 μg | EUR 147.6 |
HB-EGF Proheparin-Binding EGF-like Growth Factor Human Recombinant Protein |
||
PROTQ99075 | Regular: 50ug | EUR 380.4 |
Description: HB-EGF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 86 amino acids and having a molecular mass of 9.7kDa.;The HB-EGF is purified by proprietary chromatographic techniques. |
Human EGF Protein |
||
20-abx060144 |
|
|
HB-EGF, Human |
||
HY-P7017 | 100ug | EUR 432 |
rec EGF (human) |
||
H-7490.0100 | 0.1mg | EUR 194.4 |
Description: Sum Formula: C270H395N73O83S7; CAS# [62253-63-8] |
rec EGF (human) |
||
H-7490.0500 | 0.5mg | EUR 457.2 |
Description: Sum Formula: C270H395N73O83S7; CAS# [62253-63-8] |
Human EGF Protein |
||
PROTP01133-2 | 500ug | EUR 380.4 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. . *Animal-Free Human EGF (Catalog Number AF-100-15) has replaced Human EGF (Catalog Number 100-15) |
HB-EGF, human |
||
RC216-25 | 50ug | EUR 203.56 |
EGF (Human) antibody |
||
Y230 | 50 ul | EUR 512.4 |
Description: The EGF (Human) antibody is available in Europe and for worldwide shipping via Gentaur. |
EGF |
||
E13-007-1 | 10μg | EUR 99.6 |
EGF |
||
E13-007-2 | 50μg | EUR 138 |
EGF |
||
LF-PR003 | 200 ug | EUR 170.4 |
Description: EGF protein |
EGF |
||
MO15063 | 100 ug | EUR 490.8 |
EGF |
||
E21-029 | 10ug | EUR 411.6 |
EGF |
||
PR27006 | 500 ug | EUR 381.6 |
EGF |
||
PR27009 | 500 ug | EUR 381.6 |
Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His) |
||
CS13-10ug | 10ug | EUR 120 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His) |
||
CS13-1mg | 1mg | EUR 1064.4 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His) |
||
CS13-500ug | 500ug | EUR 759.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Heparin Binding EGF like Growth Factor/proHB-EGF(C-6His) |
||
CS13-50ug | 50ug | EUR 199.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Epidermal Growth Factor,Human Recombinant(EGF), Pichia |
||
CG016-100 | 100ug | EUR 351.6 |
Epidermal Growth Factor,Human Recombinant(EGF), Pichia |
||
CG016-101 | 1mg | EUR 1340.4 |
Epidermal Growth Factor,Human Recombinant(EGF), Pichia |
||
CG016-500 | 500ug | EUR 489.6 |
Recombinant Human Epidermal Growth Factor (rHu EGF) |
||
AK9797-0100 | 100µg | EUR 1194 |
Human CellExp? EGF, Fc Tag, Mouse recombinant |
||
P1428-10 | EUR 196.8 |
Human CellExp? EGF, Fc Tag, Mouse recombinant |
||
P1428-50 | EUR 548.4 |
BD egf human recombinant e Coli 1mg |
||
356052 | PK10 | EUR 1388.52 |
HB-EGF Human, Proheparin-Binding EGF-like Growth Factor Human Recombinant Protein, His Tag |
||
PROTQ99075-1 | Regular: 10ug | EUR 380.4 |
Description: HB-EGF His Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 109 amino acids (63-148) and having a molecular mass of 12.1kDa.;HB-EGF His is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
EGF Recombinant Protein (Animal Free) |
||
40-763 | 100 ug | EUR 323.7 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant Murine EGF is a 6.0 kDa globular protein containing 53 amino acid residues, including 3 intramolecular disulfide bonds. |
EGF Recombinant Protein (Animal Free) |
||
40-768 | 20 ug | EUR 323.7 |
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant Rat EGF is a 6.2 kDa globular protein containing 54 amino acid residues, including 3 intramolecular disulfide bonds. |
Genorise® recombinant Chicken EGF |
||
GR121004 | 5 µg | EUR 342 |
Recombinant Epidermal Growth Factor (EGF) |
||
4-RPA560Ca01 |
|
|
Description: Recombinant Dog Epidermal Growth Factor expressed in: E.coli |
Recombinant Epidermal Growth Factor (EGF) |
||
4-RPA560Ca02 |
|
|
Description: Recombinant Dog Epidermal Growth Factor expressed in: E.coli |
Recombinant Epidermal Growth Factor (EGF) |
||
4-RPA560Ca03 |
|
|
Description: Recombinant Dog Epidermal Growth Factor expressed in: E.coli |
Recombinant Epidermal Growth Factor (EGF) |
||
4-RPA560Hu01 |
|
|
Description: Recombinant Human Epidermal Growth Factor expressed in: E.coli |